Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Tumor microenvironment complexity and multidrug resistance hinder cancer treatment efficacy.
• Biomimetic nanocarriers, particularly cancer cell membrane (CCM)-coated nanoparticles (CCM-NPs), show promise in overcoming these challenges.
• CCM-NPs offer advantages like homologous targeting, prolonged circulation, and enhanced tumor penetration.

Purpose of the Study:

• To review recent advances in CCM-NPs for targeted drug delivery and cancer vaccination.
• To discuss the fabrication, characterization, mechanisms, and applications of CCM-NPs.
• To provide insights for future development of CCM-NPs in precision tumor therapy.

Main Methods:

• Literature review of recent studies on CCM-NPs.
• Analysis of CCM-NP fabrication techniques and characterization methods.
• Discussion of the mechanisms and applications of CCM-NPs in drug delivery and immunotherapy.

Main Results:

• CCM-NPs demonstrate effective homologous targeting and improved tumor penetration.
• CCM-NPs serve as versatile platforms for developing tumor vaccines by utilizing inherent tumor-associated antigens.
• Functionalizing nanoparticles with CCMs enhances drug delivery, tumor immunotherapy, and cancer vaccine efficacy.

Conclusions:

• CCM-NPs represent a significant advancement in biomimetic nanocarriers for cancer treatment.
• Further research into CCM-NPs can optimize precision tumor therapy through improved drug delivery and vaccination strategies.
• This review provides a comprehensive overview to guide future development in the field of CCM-based nanomedicine.